Amesite Inc. (AMST)
| Market Cap | 6.94M -43.8% |
| Revenue (ttm) | 341,437 +313.6% |
| Net Income | -2.98M |
| EPS | -0.65 |
| Shares Out | 6.55M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 42,551 |
| Open | 1.100 |
| Previous Close | 1.090 |
| Day's Range | 1.040 - 1.125 |
| 52-Week Range | 0.770 - 4.780 |
| Beta | 0.99 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Sep 28, 2026 |
About AMST
Amesite Inc., a technology company, engages in the marketing and development of B2C and B2B AI-driven solutions in the United States. Its products include Amesite Engage, that leverages proprietary AI infrastructure, offering cutting-edge applications that cater to both individual and professional needs; and NurseMagic, mobile healthcare app, streamlines creation of nursing notes and documentation tasks, enhances patient communication, and offers personalized guidance to nurses on patient care, medications, and handling challenging workplace si... [Read more]
Financial Performance
In fiscal year 2025, Amesite's revenue was $110,459, a decrease of -33.81% compared to the previous year's $166,881. Losses were -$3.62 million, -17.85% less than in 2024.
Financial StatementsNews
Amesite Transcript: AGM 2026
The meeting approved all proposals, including director elections, auditor ratification, equity plan amendment, and share issuance. Strategic focus is on scaling B2B healthcare solutions with AI, leveraging proven technology and expertise for repeatable growth.
Amesite Proxy statement: Proxy filing
Amesite filed a proxy statement on June 3, 2026, providing details for shareholder voting and corporate governance matters.
Amesite Proxy statement: Proxy filing
Amesite filed a proxy statement on June 3, 2026, providing details for shareholder voting and corporate governance matters.
Amesite Registration statement: Registration filing
Amesite filed a registration statement on May 26, 2026, providing details about a securities offering with the SEC.
Amesite's NurseMagic™ Wins 2,700-Census Home Care Enterprise Customer
Enterprise Deployment Validates AI-Native Infrastructure Strategy and Proves Scalable, Cost-Efficient Execution in Non-Acute Care Enterprise Deployment Validates AI-Native Infrastructure Strategy and ...
Amesite Quarterly report: Q3 2026
Amesite has published its Q3 2026 quarterly earnings report on May 18, 2026.
Amesite files prospectus for resale of shares by holders
Amesite (AMST) filed a prospectus relating to the resale by selling shareholders, from time to time, of up to 4.84M shares of common stock.
Amesite Registration statement: Registration filing
Amesite filed a registration statement on May 12, 2026, providing details about a securities offering with the SEC.
Amesite Announces Closing of Up To $7.8 Million Concurrent Registered Direct Offering and Private Placements Priced At-the-Market Under Nasdaq Rules
$2.6 million upfront with up to approximately $5.2 million of potential aggregate proceeds upon the exercise in full of warrants $2.6 million upfront with up to approximately $5.2 million of potential...
Amesite Announces Insider-Led Private Placement Priced at a Premium to Market
DETROIT, April 28, 2026 (GLOBE NEWSWIRE) -- Amesite Inc. (Nasdaq: AMST), developer of the AI‑native NurseMagic™ platform and EMR for non‑acute care, today announced that it has entered into definitive...
Amesite reports $6M concurrent registered direct offering, private placement
Amesite (AMST) announced that it has entered into definitive agreements for the purchase and sale of 696,866 shares of its common stock, at a purchase price of $1.435 per share…
Amesite Announces Up To $6 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules
DETROIT, April 27, 2026 (GLOBE NEWSWIRE) -- Amesite Inc. (Nasdaq: AMST), developer of the AI‑native NurseMagic™ platform and EMR for non‑acute care, today announced that it has entered into definitive...
Amesite announces withdrawal of registration statement n Form S-1
Amesite (AMST) announced that it has filed with the U.S. SEC a request for withdrawal of the company’s Registration Statement on Form S-1 (No. 333-295187) originally filed on April 20,…
Amesite Announces Withdrawal of Registration Statement on Form S-1
DETROIT, April 27, 2026 (GLOBE NEWSWIRE) -- Amesite Inc. (Nasdaq: AMST) (the “Company”), a leading developer of AI-powered enterprise solutions, today announced that it has filed with the U.S. Securit...
Amesite files to sell 2.78M shares of common stock
Benchmark is acting as the underwriter for this offering.
Amesite Registration statement: Registration filing
Amesite filed a registration statement on April 20, 2026, providing details about a securities offering with the SEC.
Amesite executes trading partner agreement with homecare tech platform
Amesite (AMST) entered into an Electronic Transactions Trading Partner Agreement with a homecare technology platform company, that processes tens of billions of dollars in homecare services annually. ...
Amesite Executes Trading Partner Agreement Enabling Secure Connectivity with Leading Homecare Technology Platform
Agreement Enables HIPAA-Compliant Exchange of EVV Transactions with Company Processing Billions of Dollars in Homecare Services Billed Annually Agreement Enables HIPAA-Compliant Exchange of EVV Transa...
Amesite's NurseMagic™ Named Finalist for Nurse.org “Best of Nursing: AI Nursing Tool” Award
AMST's recognition from one of the largest online nursing communities follows step-change revenue growth as company targets a post-acute market expected to exceed $800 billion AMST's recognition from ...
Amesite Quarterly report: Q2 2026
Amesite has published its Q2 2026 quarterly earnings report on February 6, 2026.
Amesite announces launch of the NurseMagic EMR
Amesite (AMST) announced the launch of the NurseMagic EMR, marking a significant expansion of the company’s platform following a year of strong sequential revenue growth and enterprise traction. The A...
Amesite Accelerates Growth With Launch of AI-Native NurseMagic™ EMR
Company enters the infrastructure layer of post-acute care following sustained revenue expansion and enterprise adoption Company enters the infrastructure layer of post-acute care following sustained ...
Amesite Announces 69% QoQ Revenue Increase in Q2 2026 and Product Plans for Coming Months
Shareholder Update Reports Positive Customer Reviews, New Segment Growth and Technology Rollouts across Post-Acute Healthcare Shareholder Update Reports Positive Customer Reviews, New Segment Growth a...
Amesite Quarterly report: Q1 2026
Amesite has published its Q1 2026 quarterly earnings report on October 24, 2025.
Amesite Annual report: Q4 2025
Amesite has published its Q4 2025 annual report on September 29, 2025.